Nationwide survey of pediatric inpatients with hand, foot, and mouth disease, herpangina, and associated complications during an epidemic period in Japan: Estimated number of hospitalized patients and factors associated with severe cases

Journal of Epidemiology

Volumn 29, Issue 9, 2019, Pages 354-362

  Takechi, Maria ^a   Fukushima, Wakaba ^a   Nakano, Takashi ^b   Inui, Miki ^a   Ohfuji, Satoko ^a   Kase, Tetsuo ^a   Ito, Kazuya ^a   Kondo, Kyoko ^c   Maeda, Akiko ^a   Shimizu, Hiroyuki ^d   Hirota, Yoshio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Enterovirus 71; Hand foot and mouth disease; Japan; Nationwide survey; Pediatric hospitalization

Indexed keywords

ADOLESCENT; CHILD; COMPLICATION; EPIDEMIC; FEMALE; HAND FOOT AND MOUTH DISEASE; HERPANGINA; HOSPITALIZATION; HUMAN; INFANT; JAPAN; MALE; NEWBORN; PRESCHOOL CHILD; QUESTIONNAIRE; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EPIDEMICS; FEMALE; HAND, FOOT AND MOUTH DISEASE; HERPANGINA; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 85071771664     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20180060     Document Type: Article

References (45)

1. Shekhar K, Lye MS, Norlijah O, et al. Deaths in children during an outbreak of hand, foot and mouth disease in Peninsular Malaysia-clinical and pathological characteristics. Med J Malaysia. 2005;60: 297-304.
2. Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med. 1999;341:929-935.
3. Komatsu H, Shimizu Y, Takeuchi Y, et al. Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatr Neurol. 1999;20:17-23.
4. Chan KP, Goh KT, Chong CY, et al. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003;9:78-85.
5. Ang LW, Koh BK, Chan KP, et al. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore. 2009;38:106-112.
6. Van Tu P, Thao NTT, Perera D, et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, Southern Vietnam, 2005. Emerg Infect Dis. 2007;13:1733-1741.
7. AbuBakar S, Sam IC, Yusof J, et al. Enterovirus 71 outbreak, Brunei. Emerg Infect Dis. 2009;15:79-82.
8. Ryu WS, Kang B, Hong J, et al. Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea. J Clin Microbiol. 2010;48:2490-2494.
9. Kim SJ, Kim JH, Kang JH, et al; Enteroviruses Complications Working Group. Risk factors for neurologic complications of hand, foot and mouth disease in the Republic of Korea, 2009. J Korean Med Sci. 2013;28:120-127.
10. Zhang SY, Xu MY, Xu HM, et al. Immunologic characterization of cytokine responses to enterovirus 71 and coxsackievirus A16 infection in children. Medicine (Baltimore). 2015;94:e1137.
11. Nguyen NTB, Pham HV, Hoang CQ, et al. Epidemiological and clinical characteristics of children who died from hand, foot and mouth disease in Vietnam, 2011. BMC Infect Dis. 2014;14:341.
12. Huang CC, Liu CC, Chang YC, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341: 936-942.
13. Wang SM, Lei HY, Huang KJ, et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003;188:564-570.
14. Chan LG, Parashar UD, Lye MS, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin Infect Dis. 2000;31:678-683.
15. Editorial Committee of Infectious Agents Surveillance Report, 2009. Annual report on findings of infectious agents in Japan, 2008. Jpn J Infect Dis. 2009;62:Supplement 8-19.
16. National Institute for Infectious Diseases. Infectious Agents Surveillance Report: virus serotypes isolated/detected from patients with hand, foot, and mouth disease 1997-2002. http://idsc.nih.go.jp/iasr/prompt/circle-g/hfm/hfm9702j.html; 2007. Accessed 04.06.17.
17. National Institute for Infectious Diseases. Infectious Agents Surveillance Report: virus serotypes isolated/detected from patients with hand, foot, and mouth disease 2003-2007. http://idsc.nih.go.jp/iasr/prompt/circle-g/hfm/hfm0307j.html; 2008. Accessed 04.06.17.
18. National Institute for Infectious Diseases. Infectious Agents Surveillance Report: virus serotypes isolated/detected from patients with hand, foot, and mouth disease 2007-2011. http://idsc.nih.go.jp/iasr/prompt/graph/data11.37j.pdf; 2011. Accessed 04.06.17.
19. National Institute for Infectious Diseases. IASR Graph Virus 2014 http://www.niid.go.jp/niid/images/iasr/arc/gv/2014/data2014.37j.csv. Accessed 05.28.18.
20. National Institute for Infectious Diseases. Hand, foot, and mouth disease and herpangina, 2007 to September 2017 (week 38). Infectious Agents Surveillance Report. 2017;38:191-193.
21. Nakamura Y, Matsumoto T, Tamakoshi A, et al. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol. 2000;10:29-33.
22. Fukushima W, Fujioka M, Kubo T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468:2715-2724.
23. National Institute for Infectious Diseases. Infectious Diseases Annual Surveillance Data. http://idsc.nih.go.jp/idwr/CDROM/Kako/H22/SyuList.html; 2010 Accessed 04.06.17.
24. National Institute for Infectious Diseases. NESID Annual Surveillance Data Sentinel-Reporting Diseases 2014-2. https://www.niid.go.jp/niid/en/survei/2085-idwr/ydata/6054-report-eb2014-2.html. Accessed 05.28.18.
25. National Institute for Infectious Diseases. IASR Graphs Virus2 (Archives). https://idsc.niid.go.jp/iasr/prompt/graph/data10.25e.pdf; 2010 Accessed 06.27.18.
26. World Health Organization: Regional Office for the Western Pacific. Table 1. in Section 5: Clinical features and case management. p. 38. In World Health Organization: Regional Office for the Western Pacific (ed.), A guide to clinical management and public health response for hand, foot and mouth disease (HFMD). WHO Regional Office for the Western Pacific, Manila; 2011. Available from: http://www.wpro.who.int/publications/docs/GuidancefortheclinicalmanagementofHFMD.pdf?ua/1.
27. Hashimoto S, Fukutomi K, Nagai M, et al. A method of interval estimation for number of patients in the nationwide epidemiological survey on intractable diseases. Nihon Koshu Eisei Zasshi. 1991;38: 880-883.
28. Hashimoto S, Fukutomi K, Nagai M, et al. A note on methods for estimating the number of patients in the nationwide epidemiological survey on intractable diseases. Nihon Koshu Eisei Zasshi. 1990;37: 768-774.
29. Wakai K, Tamakoshi A, Ohono Y, et al. Estimated prevalence of Shogren’s syndrome in Japan: findings from a nationwide epidemiological survey. J Epidemiol. 1995;5:125-129.
30. Suzuki Y, Taya K, Nakashima K, et al. Risk factors for severe hand foot and mouth disease. Pediatr Int. 2010;52:203-207.
31. Research Team for Pediatric Standard Value. Clinical Standard Value for Japanese Pediatrics. Tokyo: Japan Public Health Association; 1996. Japanese.
32. Li W, Teng G, Tong H, et al. Study on risk factors for severe hand, foot and mouth disease in China. PLoS One. 2014;9:e87603.
33. Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354:1682-1686.
34. Huang WC, Shih WL, Yang SC, et al. Predicting severe enterovirus 71 infection: age, comorbidity, and parental behavior matter. J Microbiol Immunol Infect. 2017;50:10-16.
35. Li Y, Zhu R, Qian Y, et al. The characteristics of blood glucose and WBC counts in peripheral blood of cases of hand, foot and mouth disease in China: a systematic review. PLoS One. 2012;7:e29003.
36. Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14:308-318.
37. Ooi MH, Wong SC, Podin Y, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007;44:646-656.
38. Hosoya M, Kawasaki Y, Sato M, et al. Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. Pediatr Infect Dis J. 2006;25:691-694.
39. Tian H, Yang QZ, Liang J, Dong SY, Liu ZJ, Wang LX. Clinical features and management outcomes of severe hand, foot and mouth disease. Med Princ Pract. 2012;21:355-359.
40. Pan J, Chen M, Zhang X, et al. High risk factors for severe hand, foot and mouth disease: a multicenter retrospective survey in Anhui Province China, 2008-2009. Indian J Dermatol. 2012;57:316-321.
41. Ooi MH, Wong SC, Mohan A, et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis. 2009;9:3.
42. Wang SM, Liu CC, Tseng HW, et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 1999;29: 184-190.
43. Lin TY, Chang LY, Huang YC, et al. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr. 2002;91:632-635.
44. Baker EH, Wood DM, Brennan AL, et al. Hyperglycaemia and pulmonary infection. Proc Nutr Soc. 2006;65:227-235.
45. McGuinness OP. Defective glucose homeostasis during infection. Annu Rev Nutr. 2005;25:9-35.